Saturday, November 21, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each, so you can check any claim. How we source
Press releaseGlobeNewswire· March 26, 2026

DBV Technologies publie ses résultats financiers annuels 2025 et fait le point sur ses activités

View original at globenewswire.com
“Trésorerie et équivalents de trésorerie de 194 millions de dollars au 31 décembre 2025, auxquels s'ajoutent 94 millions de dollars de produit brut supplémentaire reçu le 16 janvier 2026”
Verbatim excerpt from the source · GlobeNewswire · short snapshot: read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • DBV is pleased with the progress made in strengthening capabilities and building a company ready for the launch of Viaskin Peanut

    60% confidence
  • These estimates are based on the Company's current forecasts and exclude any additional expenses related to programs other than Viaskin Peanut, or resulting from potential licensing or acquisition operations of additional product candidates or technologies

    60% confidence
  • The Company may have based these estimates on assumptions that could prove to be inaccurate, and could consequently use its resources more quickly than anticipated

    60% confidence
  • Management estimates that the Company has sufficient resources to fund operations through the second quarter of 2027

    60% confidence
  • DBV remains firmly committed to making Viaskin Peanut available to children aged 1 to 7 years allergic to peanuts

    60% confidence
  • We approached 2025 focused on strengthening the company's financial position, completing the VITESSE study, launching the COMFORT Toddlers study, and preparing for the BLA submission and potential commercial launch in the United States

    60% confidence

Cited in these Via News reports